These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 28666993

  • 1. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RP.
    J Am Heart Assoc; 2017 Jun 30; 6(7):. PubMed ID: 28666993
    [Abstract] [Full Text] [Related]

  • 2. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators.
    Lancet; 2015 Jun 13; 385(9985):2363-70. PubMed ID: 25749644
    [Abstract] [Full Text] [Related]

  • 3. Interaction between digoxin and dronedarone in the PALLAS trial.
    Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ, PALLAS investigators.
    Circ Arrhythm Electrophysiol; 2014 Dec 13; 7(6):1019-25. PubMed ID: 25378467
    [Abstract] [Full Text] [Related]

  • 4. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F, Abellana R, Verdú-Rotellar JM, Bustamante Rangel A, Clua-Espuny JL, Muñoz MA.
    Eur J Clin Invest; 2018 Nov 13; 48(11):e13014. PubMed ID: 30091171
    [Abstract] [Full Text] [Related]

  • 5. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y, Chang S, Du X, Dong J, Xu X, Zhou Y, Lip GYH, Ma C.
    Am J Cardiovasc Drugs; 2019 Dec 13; 19(6):579-587. PubMed ID: 31077081
    [Abstract] [Full Text] [Related]

  • 6. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D, Bunting KV, Gill SK, Mehta S, Stanbury M, Jones JC, Haynes S, Calvert MJ, Deeks JJ, Steeds RP, Strauss VY, Rahimi K, Camm AJ, Griffith M, Lip GYH, Townend JN, Kirchhof P, Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team.
    JAMA; 2020 Dec 22; 324(24):2497-2508. PubMed ID: 33351042
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM, Giugliano RP, Claggett B, Gupta DK, Chandra A, Ruff CT, Antman EM, Mercuri MF, Grosso MA, Braunwald E, Solomon SD, ENGAGE AF-TIMI 48 Investigators.
    Eur J Heart Fail; 2019 Dec 22; 21(12):1571-1579. PubMed ID: 31777160
    [Abstract] [Full Text] [Related]

  • 9. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I, Panduranga P, Zubaid M, Sulaiman K, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Al Qudaimi A, Asaad N, Amin H.
    J Cardiovasc Pharmacol Ther; 2016 May 22; 21(3):273-9. PubMed ID: 26341119
    [Abstract] [Full Text] [Related]

  • 10. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D, AF-CHF investigators.
    Circ Heart Fail; 2012 Sep 01; 5(5):586-93. PubMed ID: 22798522
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G, Devasenapathy N, Zühlke L, Engel ME, Rangarajan S, Teo KK, Mayosi BM, Yusuf S, Global Rheumatic Heart Disease Registry (REMEDY) Investigators.
    Heart; 2019 Mar 01; 105(5):363-369. PubMed ID: 30209123
    [Abstract] [Full Text] [Related]

  • 15. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A.
    Eur Heart J; 2013 May 01; 34(20):1489-97. PubMed ID: 23592708
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.
    J Hypertens; 2015 Jul 01; 33(7):1480-6. PubMed ID: 25799208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Rost NS, Giugliano RP, Ruff CT, Murphy SA, Crompton AE, Norden AD, Silverman S, Singhal AB, Nicolau JC, SomaRaju B, Mercuri MF, Antman EM, Braunwald E, ENGAGE AF-TIMI 48 Investigators.
    Stroke; 2016 Aug 01; 47(8):2075-82. PubMed ID: 27387994
    [Abstract] [Full Text] [Related]

  • 20. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S, Yang YM, Zhu J, Ren JM, Wang J, Zhang H, Shao XH.
    Am J Emerg Med; 2017 Nov 01; 35(11):1589-1594. PubMed ID: 28551087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.